Omzo vs Try Ageless: Compounded GLP-1 Plans Compared

Quick verdict: Omzo focuses on clinician-guided access to compounded semaglutide and tirzepatide with prices starting at $179 and $279 respectively, while Try Ageless emphasizes three GLP-1 formats including needle-free tirzepatide oral drops from $159/mo and built-in discounts. Choose Omzo for clinician-reviewed plans and Try Ageless for format choice and lower prepaid monthly entry pricing.

Explore Omzo clinician-guided plans

Overview: Omzo vs Try Ageless at a glance

This direct comparison contrasts four main differences supported by the sources: pricing and billing model, medication formats and compound status, clinician review and prescribing process, and notable program features like bundled B12 or shipping. Both providers offer compounded GLP-1 medications prescribed by licensed U.S. clinicians. Neither provider supplies FDA approval for their compounded medications; each source explicitly states compounded products are not FDA-approved.

Pricing and billing model

Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. The evidence states Omzo charges fees that include medication costs paid to compounding pharmacies, but specific month-to-month plan structures are not supplied beyond those starting prices. Try Ageless shows per-month pricing on yearly prepaid plans: semaglutide from $199/mo, tirzepatide from $249/mo, and oral drops from $159/mo, with the lowest entry price available on the prepaid yearly plan. Try Ageless also reports a built-in discount and an extra code SLIM50 that stacks for additional savings.

How pricing shapes choice

Omzo presents single starting prices and clinician-guided plan options; Try Ageless emphasizes monthly prepaid rates and built-in discounts with format-specific pricing advantages for the oral drops.

See Try Ageless formats and pricing

Medication formats and regulatory notes

Both vendors offer compounded semaglutide and tirzepatide. Omzo specifically calls out a compounded medication program prepared by state-licensed sterile compounding pharmacies and includes the regulatory note that these compounded drugs are not FDA-approved. Try Ageless sells three formats: semaglutide injection, tirzepatide injection, and needle-free tirzepatide oral drops. Try Ageless notes that the oral tirzepatide drops are an off-label compounded format and that tirzepatide is not FDA-approved in oral form. Both sources emphasize that compounded medications have not been reviewed by the FDA for safety, effectiveness, or quality.

Clinician review, prescriptions, and flexibility

Omzo connects customers with licensed U.S. providers who determine eligibility and make the final prescribing decision; the site clarifies Omzo is not a medical practice and that clinical services are provided by third party networks of licensed clinicians. Try Ageless likewise prescribes through licensed U.S. clinicians, and it states clinicians can switch a patient between semaglutide, tirzepatide, and drops under the same plan with no new consult fee. Try Ageless highlights unlimited messaging and the ability to pause or cancel plans anytime on prepaid plans.

Program features and delivery

Omzo highlights fast, discreet delivery and FSA and HSA eligibility, while stressing that medication appearance may differ from website images and that costs are included in fees collected by Omzo. Try Ageless includes B12 in every plan for energy support, free discreet shipping, plain packaging, and notes the discount is built into every plan rather than a first-month teaser. Try Ageless also claims LegitScript certification and HIPAA compliance for its pharmacy network per the source evidence.

Comparison table

What the sources do not supply

The sources do not provide head-to-head clinical efficacy comparisons, exact month-to-month Omzo plans beyond starting prices, or state-by-state availability lists. Do not assume outcomes, insurance coverage, or universal eligibility; each provider states clinicians determine prescribing eligibility and results are not guaranteed.

Check Omzo eligibility and options

Bottom line and choice guidance

Omzo vs Try Ageless centers on clinician-guided compounded plans versus format flexibility and prepaid discounts. Omzo is positioned around clinician-reviewed GLP-1 care with stated starting prices and a compounded medication program. Try Ageless is positioned around three formats including needle-free tirzepatide drops from $159/mo on yearly plans, bundled B12, and built-in discounts.

Start with Omzo clinician-guided care

Choose Omzo if you want clinician-guided plans reviewed by licensed U.S. providers and visibility into compounded semaglutide starting at $179 or tirzepatide starting at $279. Choose Try Ageless if you prioritize the lowest advertised prepaid monthly entry price, a choice of injection or needle-free oral drops, bundled B12, and an already-applied discount plus an extra SLIM50 code. Remember that both offer compounded medications that are not FDA-approved and that clinicians determine prescription eligibility.